cyclosporine and Infections, Coronavirus

cyclosporine has been researched along with Infections, Coronavirus in 19 studies

Research

Studies (19)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (5.26)24.3611
2020's18 (94.74)2.80

Authors

AuthorsStudies
Byun, SY; Choi, I; Jeon, S; Kim, S; Ko, M; Lee, J; Park, S; Shum, D1
Behr, J; Berthold, EJ; Chakraborty, A; Hatz, R; Hausch, F; Hilgendorff, A; Ma-Lauer, Y; Staab-Weijnitz, CA; von Brunn, A; von Brunn, B1
Colpitts, CC; Gallardo-Flores, CE; Mamatis, JE; Sangwan, U; Tooley, TH; Walsh, T1
Fischer, G; Ma-Lauer, Y; Malešević, M; von Brunn, A; von Brunn, B; Zheng, Y1
Li, L; Li, W; Liu, H; Liu, L; Nashan, B; Ning, L; Shen, A; Wang, J; Yao, Z; Zhang, S; Zhao, D1
Benotmane, I; Caillard, S; Fafi-Kremer, S; Gautier, G; Marx, D; Moulin, B; Perrin, P1
Duan, Q; Feng, S; Guo, L; Li, J; Liu, J; Liu, X; Luo, W; Wang, L; Wu, Y; Xie, M; Yang, Q; Zhu, R1
Liu, W; Sun, L; Tian, L1
Ahmed-Belkacem, A; Ahnou, N; Berry, F; Brillet, R; Bruscella, P; Fourati, S; Hamadat, S; Morin-Dewaele, M; Nevers, Q; Pawlotsky, JM; Softic, L1
Axelrad, J; Chang, S; Hudesman, D; Rosen, MH; Rubin, DT1
Biglia, A; Bozzalla Cassione, E; Cavagna, L; Codullo, V; Montecucco, C; Zanframundo, G1
Cumhur Cure, M; Cure, E; Kucuk, A1
Di Lernia, V; Feliciani, C; Goldust, M1
Argaud, L; Cour, M; Ovize, M1
Fischereder, M; Guba, MO; Kemmner, S; Schönermarck, U; Stangl, M1
Becker, S; Dietzel, E; Fink, L; Gattenloehner, S; Goesmann, A; Gruber, AD; Herold, S; Hofmann, N; Hoppe, J; Kupke, A; Meier, L; Nist, A; Peteranderl, C; Sauerhering, L; Stiewe, T; Witte, B; Zimmermann, T1
Brun, P; Dubois, J; Dulière, V; Julien, T; Lina, B; Padey, B; Pizzorno, A; Rosa-Calatrava, M; Terrier, O; Traversier, A1
Han, M; Meng, F; Wei, J; Zhao, J; Zhou, J1
Beugeling, C; de Wilde, AH; Falzarano, D; Feldmann, H; Fett, C; Martellaro, C; Perlman, S; Posthuma, CC; Snijder, EJ; Zevenhoven-Dobbe, JC1

Reviews

2 review(s) available for cyclosporine and Infections, Coronavirus

ArticleYear
[Role of cyclophilin A during coronavirus replication and the antiviral activities of its inhibitors].
    Sheng wu gong cheng xue bao = Chinese journal of biotechnology, 2020, Apr-25, Volume: 36, Issue:4

    Topics: Antiviral Agents; Betacoronavirus; Coronavirus; Coronavirus Infections; COVID-19; Cyclophilin A; Cyclosporine; Humans; Pandemics; Pneumonia, Viral; SARS-CoV-2; Severe acute respiratory syndrome-related coronavirus; Virus Replication

2020
Management of Acute Severe Ulcerative Colitis in a Pregnant Woman With COVID-19 Infection: A Case Report and Review of the Literature.
    Inflammatory bowel diseases, 2020, 06-18, Volume: 26, Issue:7

    Topics: Abortion, Spontaneous; Adult; Antiviral Agents; Betacoronavirus; C-Reactive Protein; Clinical Laboratory Techniques; Colitis, Ulcerative; Coronavirus Infections; COVID-19; COVID-19 Testing; Cyclosporine; Female; Humans; Immunosuppressive Agents; Methylprednisolone; Pandemics; Patient Acuity; Pneumonia, Viral; Pregnancy; Pregnancy Complications; Remission Induction; SARS-CoV-2; Sigmoidoscopy; Treatment Outcome

2020

Other Studies

17 other study(ies) available for cyclosporine and Infections, Coronavirus

ArticleYear
Identification of Antiviral Drug Candidates against SARS-CoV-2 from FDA-Approved Drugs.
    Antimicrobial agents and chemotherapy, 2020, 06-23, Volume: 64, Issue:7

    Topics: Animals; Anti-Inflammatory Agents; Antiviral Agents; Betacoronavirus; Cell Line; Chlorocebus aethiops; Coronavirus Infections; COVID-19; Drug Evaluation, Preclinical; Drug Repositioning; Humans; Niclosamide; Pandemics; Pneumonia, Viral; Pregnenediones; SARS-CoV-2; Vero Cells

2020
Effects of immunophilin inhibitors and non-immunosuppressive analogs on coronavirus replication in human infection models.
    Frontiers in cellular and infection microbiology, 2022, Volume: 12

    Topics: Coronavirus; Coronavirus 229E, Human; Coronavirus Infections; Cyclophilins; Cyclosporine; HEK293 Cells; Humans; Immunosuppressive Agents; Luciferases, Renilla; Pharmaceutical Preparations; RNA; Tacrolimus; Tacrolimus Binding Proteins

2022
Induction of antiviral gene expression by cyclosporine A, but not inhibition of cyclophilin A or B, contributes to its restriction of human coronavirus 229E infection in a lung epithelial cell line.
    Antiviral research, 2023, Volume: 219

    Topics: Antiviral Agents; Coronavirus; Coronavirus 229E, Human; Coronavirus Infections; Cyclophilin A; Cyclosporine; Epithelial Cells; Gene Expression; Humans; Lung

2023
Influences of cyclosporin A and non-immunosuppressive derivatives on cellular cyclophilins and viral nucleocapsid protein during human coronavirus 229E replication.
    Antiviral research, 2020, Volume: 173

    Topics: Coronavirus 229E, Human; Coronavirus Infections; Coronavirus Nucleocapsid Proteins; Cyclophilin A; Cyclophilins; Cyclosporine; Host-Pathogen Interactions; Humans; Nucleocapsid Proteins; Protein Binding; Virus Replication

2020
Novel coronavirus (SARS-CoV-2) infection in a renal transplant recipient: Case report.
    American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 2020, Volume: 20, Issue:7

    Topics: Adrenal Cortex Hormones; Adult; Betacoronavirus; China; Coronavirus Infections; COVID-19; Cyclosporine; Disease Outbreaks; Drug Combinations; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Kidney Failure, Chronic; Kidney Transplantation; Living Donors; Lopinavir; Male; Pandemics; Pneumonia, Viral; Reverse Transcriptase Polymerase Chain Reaction; Ritonavir; SARS-CoV-2; Tomography, X-Ray Computed; Transplant Recipients; Treatment Outcome

2020
First case of COVID-19 in a kidney transplant recipient treated with belatacept.
    American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 2020, Volume: 20, Issue:7

    Topics: Abatacept; Coronavirus Infections; COVID-19; Cyclosporine; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Kidney Failure, Chronic; Kidney Transplantation; Lung; Male; Middle Aged; Mycophenolic Acid; Pandemics; Pneumonia, Viral; Prednisone; Radiography, Thoracic; Tomography, X-Ray Computed; Treatment Outcome

2020
Prevention and Control of COVID-19 in Chronic Kidney Disease.
    Indian journal of pediatrics, 2020, Volume: 87, Issue:7

    Topics: Betacoronavirus; Coronavirus Infections; COVID-19; Cyclosporine; Humans; Interferon-alpha; Middle East Respiratory Syndrome Coronavirus; Pandemics; Pneumonia, Viral; Renal Insufficiency, Chronic; SARS-CoV-2

2020
Inhibition of SARS-CoV-2 Infection by the Cyclophilin Inhibitor Alisporivir (Debio 025).
    Antimicrobial agents and chemotherapy, 2020, 06-23, Volume: 64, Issue:7

    Topics: Animals; Antiviral Agents; Betacoronavirus; Cell Line; Chlorocebus aethiops; Coronavirus Infections; COVID-19; Cyclophilins; Cyclosporine; Humans; Pandemics; Pneumonia, Viral; SARS-CoV-2; Vero Cells; Virus Replication

2020
COVID-19 infection in a northern-Italian cohort of systemic lupus erythematosus assessed by telemedicine.
    Annals of the rheumatic diseases, 2020, Volume: 79, Issue:10

    Topics: Adult; Aged; Aged, 80 and over; Antirheumatic Agents; Azathioprine; Betacoronavirus; Clinical Laboratory Techniques; Cohort Studies; Coronavirus Infections; Cough; COVID-19; COVID-19 Testing; Cyclosporine; Diarrhea; Dysgeusia; Dyspnea; Fatigue; Female; Fever; Glucocorticoids; Humans; Hydroxychloroquine; Immunosuppressive Agents; Incidence; Intensive Care Units; Italy; Lupus Erythematosus, Systemic; Male; Methotrexate; Middle Aged; Mycophenolic Acid; Olfaction Disorders; Pandemics; Pneumonia, Viral; Prednisone; Respiratory Distress Syndrome; SARS-CoV-2; Telemedicine

2020
Cyclosporine therapy in cytokine storm due to coronavirus disease 2019 (COVID-19).
    Rheumatology international, 2020, Volume: 40, Issue:7

    Topics: Coronavirus Infections; COVID-19; Cyclosporine; Cytokines; Humans; Immunosuppressive Agents; Pandemics; Pneumonia, Viral; Sodium-Hydrogen Exchangers

2020
Covid-19 infection in psoriasis patients treated with cyclosporin.
    Dermatologic therapy, 2020, Volume: 33, Issue:4

    Topics: Adolescent; Adult; Betacoronavirus; Comorbidity; Coronavirus Infections; COVID-19; Cyclosporine; Dermatologic Agents; Female; Humans; Male; Middle Aged; Pandemics; Pneumonia, Viral; Psoriasis; SARS-CoV-2; Young Adult

2020
Cyclosporine A: a valid candidate to treat COVID-19 patients with acute respiratory failure?
    Critical care (London, England), 2020, 06-02, Volume: 24, Issue:1

    Topics: Acute Disease; Coronavirus Infections; COVID-19; Cyclosporine; Humans; Pandemics; Pneumonia, Viral; Respiratory Insufficiency; Treatment Outcome

2020
Cyclosporine as a preferred calcineurin inhibitor in renal allograft recipients with COVID-19 infection.
    Kidney international, 2020, Volume: 98, Issue:2

    Topics: Betacoronavirus; Calcineurin; Calcineurin Inhibitors; Coronavirus Infections; COVID-19; Cyclosporine; Humans; Kidney Transplantation; Pandemics; Pneumonia; Pneumonia, Viral; SARS-CoV-2; Severe Acute Respiratory Syndrome

2020
Cyclophilin inhibitors restrict Middle East respiratory syndrome coronavirus
    The European respiratory journal, 2020, Volume: 56, Issue:5

    Topics: Alveolar Epithelial Cells; Animals; Calcineurin Inhibitors; Cell Culture Techniques; Coronavirus Infections; Cyclophilins; Cyclosporine; Disease Models, Animal; Humans; Interferon Lambda; Interferon Regulatory Factor-1; Interferons; Mice; Middle East Respiratory Syndrome Coronavirus; Virus Replication

2020
In vitro evaluation of antiviral activity of single and combined repurposable drugs against SARS-CoV-2.
    Antiviral research, 2020, Volume: 181

    Topics: Adenosine Monophosphate; Alanine; Animals; Antiviral Agents; Berberine; Betacoronavirus; Chlorocebus aethiops; Chloroquine; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Cyclosporine; Drug Antagonism; Drug Combinations; Drug Repositioning; Drug Synergism; Humans; Indoles; Lopinavir; Pandemics; Pneumonia, Viral; SARS-CoV-2; Vero Cells

2020
SARS-CoV-2 infection in immunocompromised patients: humoral versus cell-mediated immunity.
    Journal for immunotherapy of cancer, 2020, Volume: 8, Issue:2

    Topics: Adult; Antibodies, Viral; Betacoronavirus; Coronavirus Infections; COVID-19; Cyclosporine; Cytokines; Fatal Outcome; Humans; Immunity, Cellular; Immunity, Humoral; Immunocompromised Host; Male; Middle Aged; Pandemics; Pneumonia, Viral; SARS-CoV-2; T-Lymphocytes, Cytotoxic

2020
Alisporivir inhibits MERS- and SARS-coronavirus replication in cell culture, but not SARS-coronavirus infection in a mouse model.
    Virus research, 2017, 01-15, Volume: 228

    Topics: Animals; Antiviral Agents; Cell Line; Cells, Cultured; Coronavirus Infections; Cyclosporine; Cytopathogenic Effect, Viral; Disease Models, Animal; Dose-Response Relationship, Drug; Humans; Mice; Middle East Respiratory Syndrome Coronavirus; Severe Acute Respiratory Syndrome; Severe acute respiratory syndrome-related coronavirus; Virus Replication

2017